Simon Winther

VIP, Clinical Professor

Aarhus University
Country flagDenmark

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Aims This study aimed to determine the impact of left ventricular mass (LVM) on discordant stress cardiac magnetic resonance (CMR) imaging and invasive coronary angiography (ICA) in patients with suspected coronary artery disease (CAD) at coronary computed tomography angiography (CCTA). Methods and results In this substudy of the Dan-NICAD 2 trial (NCT03481712), 354 patients with suspected obstructive CAD on CCTA were examined with both rest and stress CMR and ICA for invasive physiological measurements. An abnormal stress CMR was defined as ≥2 contiguous segments with a stress perfusion defect, late gadolinium enhancement, or wall motion abnormality. CMR-derived LVM was sex-adjusted by conversion from grams to per cent. Haemodynamically obstructive CAD at ICA was defined as visual diameter stenosis >90% or FFR ≤0.80. LVM was higher in patients with an abnormal stress CMR compared to those with a normal CMR (median difference = 8.0%, P < 0.001). Patients with or without haemodynamically obstructive CAD had similar LVM (median difference = 2%, P = 0.222). Within four binary groups based on normal/abnormal stress CMR and ICA, both median LVM and index of microvascular resistance were higher in patients with discordant abnormal stress CMR and normal ICA than in patients with concordant normal stress CMR and ICA (124% vs. 111%, P = 0.001, and 29 vs. 19, P = 0.072, respectively). Conclusion In patients with suspected obstructive CAD, increased LVM can potentially confound concordance between stress CMR and ICA. This is due to increased microvascular resistance, which decreases the pressure gradient across an epicardial stenosis, resulting in a false high FFR and thus, normal ICA.

Year:

2026

Aims Risk factor-weighted clinical likelihood (RF-CL) estimates the probability of obstructive coronary artery disease (CAD) in patients without known CAD. We examined whether adding lipoprotein(a) [Lp(a)] measurements to the RF-CL model improves predictions of obstructive CAD. Methods and results In a derivation cohort (N = 4262; 54% male; mean age 58 years), the prevalence of obstructive CAD at invasive angiography with fractional flow reserve was assessed by Lp(a)-strata. On the basis of initial results, an Lp(a)-adjusted model (RF-CLLp(a)) was developed: RF-CL was multiplied by 1.5 in patients with elevated Lp(a) (≥125 nmol/L) and otherwise unchanged. Discrimination, calibration, and reclassification were compared. Findings were validated in an external validation cohort (N = 1595; 49% male; mean age 60 years) using a comparative endpoint; significant stenosis at invasive angiography or coronary computed tomography. In the derivation cohort, 473 patients (11.1%) had obstructive CAD; in the validation cohort, 206 patients (12.9%) had significant stenosis. The relative risk in patients with elevated Lp(a) was 1.51 [95% confidence interval (CI) 1.23–1.86] and 1.19 (95% CI 0.88–1.60) in the derivation and validation cohort, respectively. In the derivation cohort, the RF-CLLp(a) model showed a higher area under the receiver operating curve than the RF-CL model [0.743 (standard error 0.011) vs. 0.740 (0.013)] and better calibration in patients with elevated Lp(a). Reclassification from RF-CL to RF-CLLp(a) improved likelihood stratification in the derivation cohort but not in the validation cohort. Conclusion Adding elevated Lp(a) as a risk factor to the RF-CL model improves accuracy of obstructive CAD in patients with high Lp(a).

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (54)

Henrik Birn

VIP, Clinical Professor and Chair

Aarhus Universitet Health

DENMARK
View details

Jelmer Westra

Aarhus University

DENMARK
View details

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Holger Thiele

Leipzig University

GERMANY
View details

Morten Schmidt

Aarhus University

DENMARK
View details

Arijit Khan

Associate Professor

Aalborg University

DENMARK
View details

Marie Bodilsen Nielsen

Aarhus University

DENMARK
View details

Dominik C Benz

Group Leader

University of Zurich

SWITZERLAND
View details

Antonio J Quesada

Head of the Clinical Trials Coordination Unit

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

SPAIN
View details

Teemu Maaniitty

-

FINLAND
View details

Frederik Filip Stæger

Københavns Universitet

DENMARK
View details

Archana Kulasingam

Aarhus University

DENMARK
View details

Ana Viñuela

Academic, Lecturer (Teaching and Research)

University of Dundee

UNITED KINGDOM
View details

Ewan Pearson

Academic, Clinical Professor (Teaching and Research) of Diabetic Medicine

University of Dundee

UNITED KINGDOM
View details

Salma Raghad Karim

Aarhus University

DENMARK
View details

Henrik Toft Sørensen

VIP, Professor

Aarhus University

DENMARK
View details

Anne Mohr Drewes

Aarhus University

DENMARK
View details

Diana Gorog

Visiting Professor

Imperial College London

UNITED KINGDOM
View details

Benedikt Kessler

Professor of Biochemistry and Life Science Mass Spectrometry

University of Oxford

UNITED KINGDOM
View details

Jingyuan Fu

Full professor

University Medical Center Groningen

NETHERLANDS
View details

Mohsen Ghanbari

Associate professor

Erasmus MC

NETHERLANDS
View details

Klaus Fuglsang Kofoed

Professor

Rigshospitalet

DENMARK
View details

José Javier Fuster

Assistant Professor

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

SPAIN
View details

Maik Pietzner

Professor

Queen Mary University of London

UNITED KINGDOM
View details

Bjarne L. Nørgaard

-

DENMARK
View details

Pamela Douglas

Duke University

UNITED STATES
View details

Steffen E Petersen

Professor of Cardiovascular Medicine

Queen Mary University of London

UNITED KINGDOM
View details

Lars Christian Gormsen

VIP, Clinical Professor and Chair

Aarhus University

DENMARK
View details

Simon Cichosz

Aalborg University

DENMARK
View details

Mette Nyegaard

Head of Department

Aalborg University

DENMARK
View details

Fatima Sanchez-Cabo

Head

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

SPAIN
View details

Hanna M. Björck

Karolinska Institutet

SWEDEN
View details

Sotirios Nedios

Leipzig University

GERMANY
View details

Palle Duun Rohde

Associate Professor

Aalborg University

DENMARK
View details

Laust Dupont Rasmussen

MD, PhD

Aalborg University Hospital

DENMARK
View details

Kristian Kragholm

Aalborg University

DENMARK
View details

Julia Kraft

Charité - Universitätsmedizin Berlin

GERMANY
View details

Andreas Bugge Tinggaard

VIP, Assistant Professor

Aarhus University

DENMARK
View details

Peter Vedsted

Professor

Aarhus University

DENMARK
View details

Lau Brix

VIP, Associate Professor

Aarhus University

DENMARK
View details

Joachim Weber

Head of Strategic Science Management

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY
View details

Ronny Ralf Buechel

University Hospital of Zurich

SWITZERLAND
View details

Morten Bøttcher

VIP, Clinical Professor

Aarhus University

DENMARK
View details

Christiaan Vrints

Antwerp University Hospital

BELGIUM
View details

Jonathan Nørtoft Dahl

Aarhus University

DENMARK
View details

Kasper Bonnesen

Aarhus University

DENMARK
View details

Evald Høj Christiansen

-

DENMARK
View details

Jemma Hopewell

Professor of Precision Medicine & Epidemiology

University of Oxford

UNITED KINGDOM
View details

Hanne Mari Skou Jørgensen

Associate Professor

Aarhus University

DENMARK
View details

Juhani Knuuti

-

FINLAND
View details

Samuel Emil Schmidt

Aalborg University

DENMARK
View details

A. Zhernakova

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Morten Hasselstrøm Jensen

Aalborg University

DENMARK
View details

Lars Poulsen Tolbod

Associate Professor

Aarhus University

DENMARK
View details